Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
5359 studies found for:    Etopósido OR HIV [CONDITION]
Show Display Options
Rank Status Study
1 Enrolling by invitation The Effect of HPV Vaccination on Recurrence Rates in HIV Patients With Condylomata
Conditions: HIV Positive;   Anal Condylomata;   Anal Warts;   HIV Infections
Interventions: Drug: Saline;   Drug: Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recombinant Vaccine
2 Terminated Safety and Efficacy of Ampligen in the Treatment of HIV Patients Failing HAART
Conditions: HIV Seropositivity;   HIV Infection
Intervention: Drug: poly I-poly C12U
3 Completed Efficacy Study of the Vaginal Gel Carraguard to Prevent HIV Transmission
Conditions: HIV Infections;   AIDS;   Sexually Transmitted Diseases;   HIV Seroconversion
Intervention: Drug: Carraguard (PC-515)
4 Completed A Study of Megestrol Acetate Alone or in Combination With Testosterone Enanthate Drug in the Treatment of HIV-Associated Weight Loss
Conditions: HIV Infections;   HIV Wasting Syndrome
Interventions: Drug: Testosterone enanthate;   Drug: Megestrol acetate
5 Completed A Study to Evaluate the Effect of Nandrolone Decanoate in Women With HIV-Associated Weight Loss
Conditions: HIV Infections;   HIV Wasting Syndrome
Intervention: Drug: Nandrolone decanoate
6 Completed Effects of Potent Antiretroviral Therapy on Kaposi s Sarcoma
Conditions: HIV Seropositivity;   Kaposi's Sarcoma;   HIV Infections
Intervention:
7 Completed The Role of Ampligen in Strategic Therapeutic Intervention (STI) of HAART
Conditions: HIV Seropositivity;   HIV Infection
Intervention: Drug: poly I-poly C12U
8 Completed Evaluate Weight Gain Using 2 Different Formulations of Megestrol Acetate Oral Suspension for AIDS-Related Weight Loss
Conditions: HIV Infections;   Unintended Weight Loss;   Cachexia;   Anorexia;   AIDS Wasting Syndrome;   HIV Wasting Syndrome
Interventions: Drug: Megestrol acetate oral suspension nanocrystal dispersion 115 mg/mL;   Drug: Megestrol acetate oral suspension 40 mg/mL
9 Completed A Study to Evaluate High Protein Supplementation in HIV-Positive Patients With Stable Weight Loss
Conditions: HIV Infections;   HIV Wasting Syndrome
Intervention: Drug: Optimune oral nutritional supplement
10 Completed The Effect of Anti-HIV Treatment on Body Characteristics of HIV-Infected Children
Conditions: HIV Infections;   HIV Wasting Syndrome;   Lipodystrophy
Intervention:
11 Completed A Study of Physical and Metabolic Abnormalities in HIV Infected and Uninfected Children and Youth
Conditions: HIV Infections;   HIV-Associated Lipodystrophy Syndrome;   HIV Lipodystrophy Syndrome;   Lipodystrophy;   Dyslipidemia;   Osteoporosis;   Osteopenia
Intervention:
12 Terminated Study Evaluating the Impact on Fat Distribution of Nucleoside Reverse Transcriptase Inhibitor (NRTI)-Sparing Regimens in Antiretroviral Experienced Patients With Lipoatrophy
Conditions: HIV Infections;   HIV Lipodystrophy Syndrome
Interventions: Drug: non-nucleoside reverse transcriptase inhibitors;   Drug: nucleoside reverse transcriptase inhibitors;   Drug: protease inhibitors
13 Terminated Evaluation of the Occurrence of Lipoatrophy in HIV-1 Infected Naive Patients
Conditions: HIV Infections;   HIV-Associated Lipodystrophy Syndrome
Interventions: Drug: non-nucleoside reverse transcriptase inhibitors;   Drug: nucleoside reverse transcriptase inhibitors;   Drug: protease inhibitor
14 Terminated Facial Lipoatrophy Trial: Immediate Versus Deferred Injections of Poly-L-Lactic Acid for HIV Facial Lipoatrophy
Conditions: HIV-Associated Lipodystrophy;   HIV Infections
Intervention: Device: poly-L-lactic acid
15 Completed
Has Results
Growth Hormone and/or Rosiglitazone for HIV-Associated Increased Abdominal Fat and Insulin Resistance
Conditions: HIV-Associated Lipodystrophy Syndrome;   Insulin Resistance;   HIV Infections;   Metabolic Syndrome X;   Body Weight Changes
Interventions: Drug: Rosiglitazone;   Drug: Recombinant human growth hormone + rosiglitazone
16 Unknown  MEDICLAS Study (Metabolic Effects of Different Classes of AntiretroviralS)
Conditions: HIV Infections;   HIV-Associated Lipodystrophy Syndrome
Interventions: Drug: Lopinavir/ritonavir + zidovudine + lamivudine;   Drug: Lopinavir/ritonavir + nevirapine
17 Completed An Evaluation of a Rapid Test for HIV
Condition: HIV Seropositivity
Intervention: Device: Rapid testing for HIV
18 Terminated Effect of Pioglitazone on HIV-1 Related Lipoatrophy: a Randomized, Double Blind, Placebo-Controlled Trial in 130 Patients
Conditions: HIV-Associated Lipodystrophy Syndrome;   HIV Infections
Intervention: Drug: Pioglitazone
19 Completed Intermittent Preventive Treatment of Malaria in HIV-Seropositive Pregnant Women in Zambia
Conditions: Placental Malaria Infection;   HIV Infections;   Stillbirth;   Prematurity;   Neonatal Deaths
Intervention: Drug: Sulfadoxine-pyrimethamine (Fansidar)
20 Completed Comparison of HIV Clinic-Based Treatment With Buprenorphine Versus Referred Care in Heroin-Dependent Participants
Conditions: Opiate Dependence;   HIV Seropositivity;   HIV Infections
Interventions: Behavioral: Clinic-based substance abuse treatment with buprenorphine;   Behavioral: Case management and referred substance abuse treatment

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years